Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-10-04-Speech-4-027"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2001-10-04"^^xsd:date2
dcterms:Is Part Of	lp_eu:Poverty reduction (combating the major transmissible diseases)2
dcterms:Language	"da"^^xsd:language2
lpv:document identification number	"en.20011004.2.4-027"2
lpv:hasSubsequent	lp_eu:2001-10-04-Speech-4-0282
lpv:speaker	lp:Ulla Margrethe Sandbæk2
lpv:spokenAs	substitute; EMPL (2000-03-07--2002-01-14)3 member; Committee on Development and Cooperation (1999-07-21--2002-01-14)3 substitute; Committee on the Environment, Public Health and Consumer Policy (1999-07-21--2002-01-14)3 member; Members from the European Parliament to the Joint Parliamentary Assembly of the Agreement between the African, Caribbean and Pacific States and the European Union (ACP-EU) (1999-09-14--2002-01-14)3 substitute; Temporary committee on human genetics and other new technologies in modern medicine (2000-12-13--2001-11-29)3 unknown; JuniBevægelsen (1999-07-20--2004-07-19)3 member; EDD (1999-07-20--2004-07-19)3
lpv:translated text	"Mr President, it is now already a year since I took part in the round-table conference on 29 September, in which everyone agreed that no time was to be wasted in obtaining practical results in the fight against transmissible diseases. Since then, however, nothing much has happened. The Commission has acknowledged the right of poor countries to issue compulsory licences, but what does the Commission intend to do to bring about the necessary transfer of technology so that poor countries themselves can produce medicine? Why have we not yet seen initiatives to enable African technicians in African factories to produce medicines to combat tuberculosis, malaria and HIV? Economically speaking, this is possible. We are not talking in terms of huge investments to start up local production. The necessary transfer of technology might, in addition, be envisaged in terms of allowing those employed in the medical sector in the EU to spend a couple of years in developing countries, working on such technology transfer programmes. It is crucial to improve the skills of doctors, scientists, nurses and technicians in the poorest countries. They must be involved in research and development, not by inviting them to European conferences – where they are likely to receive subsistence allowances – but by providing the institutions in which they work with equipment, training and communication facilities so that well-educated people living and working under incredibly difficult conditions are motivated to remain in their own countries. Five malaria vaccines have now been developed – an extremely important step, given the fact that malaria is the disease that kills most people. And what is the EU doing? True, we have plans to set up a European platform to test the vaccine, even if there is already a fully developed African platform. Does it not make sense for the vaccine to be tested by Africans in Africa, or are Africans only good enough to act as subjects of experiments by European scientists? Let us forget all about setting up this European Clinical Trials Platform and instead support the pan-African network, AMVTN, which is just about to be converted into a fund. It would save a huge amount of time and thus save millions of human lives, and it would save money. It would also show that we recognise other people’s right to take charge of their own destinies, and it would provide them with the necessary transfer of technology. It would be a fantastic first step on the way to taking action. We have heard enough fine, but empty, words. I should like, then, to thank Mr Khanbhai."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph